| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Giuseppe Cosentino, Paolo Prunetti, Giulia Tammam, Chiara Zaffina, Matteo Gastaldi, Cristina Tassorelli, Enrico Alfonsi, Massimiliano Todisc. Diagnostic accuracy of voluntary and stimulated neuromuscular jitter studies in ocular myasthenia gravis. Muscle & nerve. 2024-07-13. PMID:39001646. |
the study aimed to compare these two techniques in the same population of patients with suspected ocular myasthenia gravis (omg). |
2024-07-13 |
2024-07-15 |
Not clear |
| Sui H Wong, Matthew James Bancroft, Vijay K Tailor, Mohamed Abbas, Akila Sekar, Claire Noble, Maria Theodorou, Diego Kask. Ocular myasthenia gravis saccades as a measure of extraocular muscle function. Frontiers in ophthalmology. vol 2. 2024-07-10. PMID:38983530. |
it is important to understand the pathophysiology of ocular myasthenia gravis (omg) to improve treatment. |
2024-07-10 |
2024-07-12 |
Not clear |
| Sui Hsien Won. Advocating Patient-Centred Research in Ocular Myasthenia Gravis (OMG): A Call for an OMG Research Consortium. Frontiers in ophthalmology. vol 2. 2024-07-10. PMID:38983533. |
advocating patient-centred research in ocular myasthenia gravis (omg): a call for an omg research consortium. |
2024-07-10 |
2024-07-12 |
Not clear |
| Jianqiang Li, Chujie Zhu, Mingming Zhao, Xi Xu, Linna Zhao, Wenxiu Cheng, Suqin Liu, Jingchen Zou, Ji-Jiang Yang, Jian Yi. OMGMed: Advanced System for Ocular Myasthenia Gravis Diagnosis via Eye Image Segmentation. Bioengineering (Basel, Switzerland). vol 11. issue 6. 2024-06-27. PMID:38927831. |
this paper presents an eye image segmentation-based computer-aided system for automatic diagnosis of ocular myasthenia gravis (omg), called omgmed. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jaron C Sanchez, Markeeta T Belmar, Jason Sanchez, Joseph L Mercen, Jose Priet. A Male Patient Presents With Isolated Abducens Nerve Palsy: An Atypical Presentation of Ocular Myasthenia Gravis. Cureus. vol 16. issue 4. 2024-05-06. PMID:38707069. |
when myasthenia gravis is isolated to only ocular symptoms, it is referred to as ocular myasthenia gravis (omg). |
2024-05-06 |
2024-05-08 |
Not clear |
| Thanathon Anutraungkool, Tanyatuth Padungkiatsagul, Panitha Jindahra, Kavin Vanikiet. Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-05-01. PMID:38686013. |
to report the prevalences of other non-thyroid autoimmune diseases and identify factors associated with their presence in ocular myasthenia gravis (omg) subjects. |
2024-05-01 |
2024-05-03 |
human |
| Yulia Valko, Magdalena A Wirth, Fabienne C Fierz, Marianne K Schesny, Sally Rosengren, Tanja Schmückle-Meier, Christopher J Bockisch, Dominik Straumann, Bettina Schreiner, Konrad P Webe. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia. Neurology. vol 102. issue 10. 2024-04-26. PMID:38669629. |
we developed repetitive ocular vestibular-evoked myogenic potentials (rovemp) as an electrophysiologic test that allows us to elicit the characteristic decrement of extraocular muscles in patients with ocular myasthenia gravis (omg). |
2024-04-26 |
2024-04-29 |
Not clear |
| Jan L De Bleecker, Gauthier Remiche, Alicia Alonso-Jiménez, Vinciane Van Parys, Véronique Bissay, Stéphanie Delstanche, Kristl G Claey. Recommendations for the management of myasthenia gravis in Belgium. Acta neurologica Belgica. 2024-04-22. PMID:38649556. |
it includes recommendations for treatment of adult patients with generalized myasthenia gravis (gmg) or ocular myasthenia gravis (omg). |
2024-04-22 |
2024-04-26 |
Not clear |
| Takuma Goto, Akiko Kimura, Akiko Masuda, Yoshihito Mochizuki, Fumi Gom. Clinical features of double seronegative ocular myasthenia gravis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2024-02-28. PMID:38416235. |
to clarify the clinical features of patients with double seronegative (ds) ocular myasthenia gravis (omg). |
2024-02-28 |
2024-03-01 |
Not clear |
| Miriam Kessi, Yulin Tang, Baiyu Chen, Guoli Wang, Ciliu Zhang, Fang He, Jing Peng, Fei Yin, Lifen Yan. Pediatric Ocular Myasthenia Gravis: Single-Center Experience. Pediatric neurology. vol 153. 2024-02-21. PMID:38382246. |
currently, there is no universally accepted standard treatment for ocular myasthenia gravis (omg) in children. |
2024-02-21 |
2024-02-24 |
Not clear |
| J McCallion, A Borsi, W Noel, J Lee, W Karmous, S Sattler, G M Boggia, E J Hardy, C R Mitchell, S A Mitchell, Nils Erik Gilhu. Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa. BMC neurology. vol 24. issue 1. 2024-02-09. PMID:38336636. |
myasthenia gravis (mg) is a rare autoimmune disease characterised by muscle weakness, and progression from ocular (omg) to generalised (gmg) symptoms results in a substantial negative impact on quality of life (qol). |
2024-02-09 |
2024-02-12 |
Not clear |
| Minghua Shi, Zhuneng Lu, Aijiao Qin, Jing Cheng, Simin Chen, Yiqiao Xin. A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis. BMC ophthalmology. vol 24. issue 1. 2024-01-23. PMID:38254041. |
to evaluate the efficacy and safety of peribulbar triamcinolone acetonide injection for treating ocular myasthenia gravis (omg), with a comparison of traditional oral drug therapy. |
2024-01-23 |
2024-01-25 |
Not clear |
| Kai-Yue Zhang, Wei-Wei Duan, Yue-Bei Luo, Yi Li, Jue Hu, Huan Yan. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study. Orphanet journal of rare diseases. vol 19. issue 1. 2024-01-19. PMID:38243274. |
oral prednisone has been recognized as the first-line therapy for the treatment of ocular myasthenia gravis (omg). |
2024-01-19 |
2024-01-22 |
Not clear |
| Laura Wilson, Helen Davi. The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. The British and Irish orthoptic journal. vol 19. issue 1. 2023-12-04. PMID:38046270. |
the conversion of ocular myasthenia gravis (omg) to generalised myasthenia gravis (gmg) is reported to differ depending on the presence of generalisation risk factors (mazzoli et al. |
2023-12-04 |
2023-12-10 |
Not clear |
| Yajun Mu, Xin Huang, Yuanting Yang, Ziqing Huang, Jiaxin Chen, Shiyin Li, Yuying Dong, Fangyuan Chen, Rijia Zhang, Jian Chen, Huiyu Feng, Qing Zho. Study of serum exosome miRNA as a biomarker for early onset adult ouclar myasthenia gravis. Gene. 2023-11-28. PMID:38013129. |
by extracting and sequencing mirnas from serum exosomes of patients with early-onset ocular myasthenia gravis (omg), generalized myasthenia gravis (gmg) and healthy controls, we screened differentially expressed mirnas and explored the possibility as potential biomarkers for early-onset omg. |
2023-11-28 |
2023-11-29 |
Not clear |
| Kenshiro Fuse, Amane Araki, Saori Morozumi, Keizo Yasui, Tomoyuki Kazuta, Seiya Noda, Masahisa Katsun. [A case of anti-acetylcholine receptor antibody-positive ocular myasthenia gravis with anti-titin antibody and anti-Kv1.4 antibody positive inflammatory myopathy]. Rinsho shinkeigaku = Clinical neurology. 2023-11-21. PMID:37989286. |
an 84-year-old man was diagnosed with anti-acetylcholine receptor (achr) antibody-positive ocular myasthenia gravis (omg) at the age of 77 and received treatment. |
2023-11-21 |
2023-11-29 |
Not clear |
| Rui-Yan Wang, Hui Chen, Zhi-Xin Huang, Yong Chen, Jian-Min Zhon. [Clinical effect of different immunosuppressive treatment regimens in children with ocular myasthenia gravis: a retrospective analysis]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. vol 25. issue 10. 2023-10-31. PMID:37905760. |
to investigate the clinical effect of different immunosuppressive treatment regimens in children with ocular myasthenia gravis (omg). |
2023-10-31 |
2023-11-08 |
Not clear |
| Jingsi Wang, Hongyu Zhou, Hongxi Chen, Huiyu Feng, Ting Chang, Chao Sun, Rongjing Guo, Zhe Ruan, Fangfang Bi, Jing Li, Jianwen Wang, Kang Wang, Gaoting Ma, Shaoyuan Lei, Chunxiu Wang, Zhihong Wang, Feifei Huang, Shu Zhang, Qi Wen, Yaye Wang, Yanan Sun, Yun Li, Nairong Xie, Haoran Liu, Yuting Jiang, Lin Lei, Zhirong Fan, Shengyao Su, Yan Lu, Li Di, Min Xu, Min Wang, Hai Chen, Suobin Wang, Xinmei Wen, Wenjia Zhu, Jianying Duo, Yue Huang, Deqiang Zheng, Yuwei D. Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study. QJM : monthly journal of the Association of Physicians. 2023-10-06. PMID:37802883. |
the environmental effects on the prognosis of ocular myasthenia gravis (omg) remain largely unexplored. |
2023-10-06 |
2023-10-15 |
Not clear |
| Wu Yunqing, Cui Shilei, Li Yong, Li Qing, Shi Xiaohong, Wang Jiawe. Cavernous Sinus MRI Findings in Inflammatory and Ischemic Oculomotor Cranial Nerve Palsies. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023-09-26. PMID:37751328. |
this study explored the cavernous sinus mri findings for cavernous sinus idiopathic inflammation (inflammation group), microvascular ischemic ocn palsy (ischemic group), and ocular myasthenia gravis (omg group) patients. |
2023-09-26 |
2023-10-07 |
Not clear |
| Neşe Çelebisoy, Asim Orujov, Fidan Balayeva, Hüseyin Nezih Özdemir, Ayşın Kısabay Ak, Figen Gökça. Prognostic predictors of remission in ocular myasthenia gravis. Acta neurologica Belgica. vol 123. issue 5. 2023-09-16. PMID:36474006. |
ocular myasthenia gravis (omg) constitutes 15% of all myasthenia gravis patients. |
2023-09-16 |
2023-10-07 |
Not clear |